We are live on ! Find out more
WJA

Williams Jones & Associates Portfolio holdings

AUM $4.82B
1-Year Est. Return 19.95%
This Fund
S&P 500
This Quarter Est. Return
-13.68%
1 Year Est. Return
+19.95%
3 Year Est. Return
+72.12%
5 Year Est. Return
+86.19%
10 Year Est. Return
AUM
$3.69B
AUM Growth
-$1.27B
Cap. Flow
-$526M
Cap. Flow %
-14.27%
Top 10 Hldgs %
28.85%
Holding
464
New
10
Increased
119
Reduced
184
Closed
63

Top Buys

Rank Stock Value
1
XYL icon
Xylem
XYL
+$4.98M
2
IDXX icon
Idexx Laboratories
IDXX
+$4.97M
3
ET icon
Energy Transfer Partners
ET
+$4.32M
4
CI icon
Cigna
CI
+$3.57M
5
ZTS icon
Zoetis
ZTS
+$2.69M

Sector Composition

Rank Sector Weight
1 Technology 16.73%
2 Healthcare 15.72%
3 Financials 14.57%
4 Industrials 9.48%
5 Communication Services 8.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SHW icon
326
Sherwin-Williams
SHW
$89.8B
$201K 0.01%
1,536
+6
+0.4% +$809
SREV
327
DELISTED
ServiceSource International, Inc.
SREV
$184K 0.01%
+170,027
New +$268K
METC icon
328
Ramaco Resources Class A
METC
$649M
$160K ﹤0.01%
33,385
NMRK icon
329
Newmark Group
NMRK
$2.63B
$155K ﹤0.01%
+19,277
New +$182K
PBCT
330
DELISTED
People's United Financial Inc
PBCT
$148K ﹤0.01%
10,233
NETI
331
DELISTED
Eneti Inc.
NETI
$141K ﹤0.01%
2,738
-1,937
-41% -$111K
FBRX icon
332
Forte Biosciences
FBRX
$1.57B
$115K ﹤0.01%
37
NIHD
333
DELISTED
NII Holdings, Inc. Common Stock
NIHD
$110K ﹤0.01%
25,000
BGC icon
334
BGC Group
BGC
$4.89B
$103K ﹤0.01%
20,000
-126,948
-86% -$836K
VHC icon
335
VirnetX Holding Corp
VHC
$63.1M
$85K ﹤0.01%
1,770
+2
+0.1% +$136
SNDA icon
336
Sonida Senior Living
SNDA
$1.91B
$81K ﹤0.01%
793
LCTX icon
337
Lineage Cell Therapeutics
LCTX
$278M
$74K ﹤0.01%
80,740
-11,546
-13% -$17.7K
LPG icon
338
Dorian LPG
LPG
$1.96B
$74K ﹤0.01%
12,700
HIX
339
Western Asset High Income Fund II
HIX
$355M
$70K ﹤0.01%
12,085
PETX
340
DELISTED
Aratana Therapeutics, Inc.
PETX
$62K ﹤0.01%
10,045
-7,000
-41% -$42.7K
ESV
341
DELISTED
Ensco Rowan plc
ESV
$61K ﹤0.01%
4,300
+850
+25% +$21.9K
AUD
342
DELISTED
Audacy, Inc.
AUD
$57K ﹤0.01%
10,000
-470,885
-98% -$3.13M
ACB
343
Aurora Cannabis
ACB
$185M
$55K ﹤0.01%
+93
New +$68.6K
YELL
344
DELISTED
Yellow Corporation Common Stock
YELL
$54K ﹤0.01%
17,000
-69,405
-80% -$442K
TK icon
345
Teekay
TK
$985M
$34K ﹤0.01%
10,200
-2,000
-16% -$11K
RGN
346
DELISTED
REGENERX BIOPHARMACEUTICALS
RGN
$23K ﹤0.01%
150,000
MDXG icon
347
MiMedx Group
MDXG
$633M
$21K ﹤0.01%
12,000
-6,500
-35% -$36.1K
IMDX
348
Insight Molecular Diagnostics
IMDX
$156M
$21K ﹤0.01%
751
AST
349
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$19K ﹤0.01%
30,100
IW
350
DELISTED
IMAGEWARE SYSTEMS,INC
IW
$18K ﹤0.01%
20,000

Similar funds

Williams Jones & Associates's Q4 2018 Portfolio in Review

As of Q4 2018, Williams Jones & Associates held 464 positions worth $3.69B, down 26% from $4.96B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Williams Jones & Associates withdrew a net $526M in Q4 2018, closing 63 positions and reducing 184 holdings. Its most notable exit was Express Scripts Holding Company, an estimated $6.97M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Williams Jones & Associates opened a new position in Linde worth $646K.

  • Williams Jones & Associates's largest Q4 2018 buy was Linde: 4,142 shares worth $646K.
  • Williams Jones & Associates added most to Xylem in Q4 2018, an estimated $4.98M increase.
  • Williams Jones & Associates's biggest Q4 2018 reduction was DuPont de Nemours, cutting an estimated $40.5M.
  • Williams Jones & Associates fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $6.97M.
  • Williams Jones & Associates's ten largest holdings make up 29% of its $3.69B portfolio in Q4 2018.
  • Williams Jones & Associates opened 10 new positions and closed 63 in Q4 2018.
  • Williams Jones & Associates's portfolio value fell 26% quarter-over-quarter to $3.69B.

Based on Williams Jones & Associates's 13F filing for Q4 2018, filed 14 Feb 2019.